Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quantumzyme (QTZM) Cost of Revenue (2016 - 2018)

Quantumzyme (QTZM) has 4 years of Cost of Revenue data on record, last reported at $29007.0 in Q2 2018.

  • For Q2 2018, Cost of Revenue rose 4.35% year-over-year to $29007.0; the TTM value through Jul 2018 reached $89345.0, down 15.59%, while the annual FY2018 figure was $89345.0, 15.59% down from the prior year.
  • Cost of Revenue reached $29007.0 in Q2 2018 per QTZM's latest filing, down from $31118.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $181948.0 in Q1 2017 and bottomed at -$134550.0 in Q3 2017.
  • Average Cost of Revenue over 4 years is $27186.5, with a median of $29007.0 recorded in 2018.
  • The widest YoY moves for Cost of Revenue: up 634.34% in 2017, down 557.62% in 2017.
  • A 4-year view of Cost of Revenue shows it stood at $21044.0 in 2015, then skyrocketed by 45.65% to $30651.0 in 2016, then fell by 4.67% to $29220.0 in 2017, then fell by 0.73% to $29007.0 in 2018.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $29007.0 in Q2 2018, $31118.0 in Q1 2018, and $29220.0 in Q4 2017.